# Founder Dilution Explained: Cap Tables, Pro Rata, 409A and Secondary Sales

July 2, 2026 · Updated November 13, 2026 · By [Josh May](https://www.pitchprotocol.vc/team.html#josh-may)

Dilution is the fall in your ownership percentage every time the company issues new shares. Over a typical path of a pre-seed SAFE, a priced seed and a Series A, Carta's data shows the median founding team going from 100% to about 56% at the seed and 36% at the Series A. Cap tables, option pools, pro rata rights, 409A valuations and secondary sales are all pieces of that same arithmetic, and this page works through each with one example company.

**TL;DR:** Your stake after a round is your stake before it times one minus the share sold. Carta's Q2 2026 medians: 19.4% dilution at seed, 18.7% at Series A, 13.4% at Series B, with founders at 56% after seed and 36% after Series A. The option pool is created or topped up in the pre-money, so founders pay for it. Pro rata rights let an investor buy its share of the next round to hold its percentage. A 409A valuation prices common stock, is presumed reasonable for 12 months, and a bad one costs the option holder a 20% additional tax. A secondary sale moves existing shares with board consent and usually a right of first refusal.

## The one formula behind every term on this page

When a company sells new shares, your share count does not change but the total does, so your percentage falls. Your ownership after a round equals your ownership before it multiplied by one minus the share of the company sold. A round that sells 20% of the company takes every existing holder from X to 0.8X. That is dilution, and the cap table is just the ledger that records it. Pro rata rights are a contract that lets an investor buy enough of the new shares to escape it. A 409A valuation prices the common stock that is left over after the investors' preferred stock takes its rights. A secondary sale is the one transaction on this page that changes who owns the shares without issuing any new ones.

## A worked cap table from incorporation to Series A

The table follows two founders through a pre-seed SAFE, a priced seed and a Series A. The percentages are fully diluted, meaning every SAFE and option is counted as if it had converted or been exercised, which is the basis investors use. The round sizes are illustrative; the mechanics are the standard ones.

| Event | Founders | SAFE investors | Seed investors | Series A investors | Option pool | What happened |
| --- | --- | --- | --- | --- | --- | --- |
| Incorporation | 100% (50% each) | | | | | 10,000,000 founder shares |
| Pre-seed: $1M post-money SAFE, $10M cap | 100% (50% each) | 10% at conversion | | | | Nothing changes on paper until the SAFE converts; the SAFE holders will own 10% of the company as it stands before the seed money |
| Seed: $4M at $16M pre-money, 10% pool created | 62% (31% each) | 8% | 20% | | 10% | $20M post-money. The SAFE converts into 10% of the pre-money capitalization, pool included, then everyone is diluted by the 20% sold |
| Between rounds: 4% granted to hires | 62% | 8% | 20% | | 6% unallocated, 4% granted | Grants move shares from the pool to people; nobody else is diluted |
| Series A: $15M at $60M pre-money, pool topped up to 10% | 46% (23% each) | 6% | 15% | 20% | 10% unallocated, 3% granted | $75M post-money. The 5.5% top-up sits in the pre-money, so existing holders pay for it; the Series A investors do not |

Three things in that table surprise most first-time founders. The SAFE did not dilute anyone on the day it was signed; it diluted the founders at the seed, when it converted. The option pool diluted the founders twice, once when it was created and once when it was topped up, and never the investors who asked for it, because both times it was placed in the pre-money. And the founders' combined stake fell from 100% to 46% while the company's post-money valuation rose from zero to $75 million, which is the trade venture financing is built on.

## What the benchmarks say

Carta's data on rounds raised from 2021 through 2025 puts the median founding team at about 56% of fully diluted equity by the time it raises a seed round and 36% by the Series A. Its Q2 2026 benchmarks put median dilution at 19.4% in a seed round, 18.7% in a Series A and 13.4% in a Series B, with median post-money valuations of $23.9 million, $76.3 million and $166.2 million. Carta also reports that at the seed stage the median employee option pool is 12.1% of equity. If your own model lands near those numbers, you are negotiating a normal round.

## Cap tables: what they show and what investors check

A cap table lists every holder of shares, options, warrants, SAFEs and convertible notes, with each holder's count and percentage on two bases: as issued today, and fully diluted. Investors read the fully diluted column, because it is what everyone will own once the round closes and the instruments convert. Keep it in a cap table tool such as Carta or Pulley rather than a spreadsheet; the tool tracks vesting, models conversions and produces the 409A valuation when you need one.

Five things an investor checks before a term sheet, and what a clean answer looks like:

- **Founder ownership.** Enough combined founder equity to stay motivated through several more rounds. Below the Carta medians above, expect questions.
- **The option pool.** Enough unallocated equity for the next 12 to 18 months of hires, with standard vesting on every grant.
- **Overhang.** Dozens of small angel holdings make every future consent and information right harder to manage.
- **Conversion math.** SAFEs at different caps and notes with different discounts convert differently; model it before the investor does.
- **Hidden problems.** Co-founder shares that vested without a repurchase right, expired options still on the books, and IP that was never assigned to the company all surface in diligence. Cooley's guidance for founders describes the vesting and right-of-first-refusal provisions that founder stock normally carries so that a departing co-founder does not leave with a full stake.

## The option pool, and why it dilutes you more than the investors

Carta describes the common rule of thumb as a pool of about 10% of company shares, and cites HSBC Innovation Banking's 2026 term sheet guide for the most common range of 10% to 15%, with 10% the most frequent choice; its own term sheet data found a pool created or topped up in 71% of cases. The number matters less than where it sits. When the pool is created or topped up inside the pre-money valuation, the shares come out of the existing holders, as in the table above. Cooley GO's advice is to build an option budget from the hires your plan actually needs over the next 12 to 18 months, which usually yields a credible pool smaller than the abstract percentage an investor says is standard. The [option pool refresh guide](https://www.pitchprotocol.vc/blog/option-pool-refresh-explained/) walks through that negotiation.

## Pro rata rights: the right to not be diluted

A pro rata right lets an existing investor buy its proportionate share of the new securities in a later round, so that its percentage does not fall. In the NVCA model investors' rights agreement it appears as a right of first offer: if the company proposes to sell new securities, it must first offer each major investor the portion that the investor's fully diluted holding bears to the company's total fully diluted stock. Y Combinator's post-money SAFE keeps the right out of the SAFE itself and in an optional side letter, which grants the investor the right to buy its pro rata share of the preferred stock sold in the round where the SAFE converts, with the share defined as the SAFE shares divided by the company's capitalization.

In the worked example, the seed investors held 20% going into the Series A. Their pro rata share of the $15 million round is $3 million; if they write that check they finish close to their 20% instead of the 15% the table shows. That is the whole point of the clause, and it is why it matters more in a hot round than a slow one: every dollar an existing investor takes up is a dollar the new lead cannot buy. Super pro rata rights, which let an investor buy more than its proportionate share, raise the stakes further and are worth a real negotiation. Standard pro rata is usually not.

## 409A valuations: pricing the common stock

A 409A valuation is an independent appraisal of the fair market value of your common stock, used to set the strike price of stock options. The rule comes from Section 409A of the tax code. If options are granted below fair market value without a defensible valuation, the holder owes ordinary income tax on the deferred amount plus an additional tax equal to 20% of it, and interest, under section 409A(a)(1)(B); the IRS's audit guide notes that those additional taxes fall on the employee, not the employer. The Treasury regulation at 1.409A-1(b)(5)(iv)(B) presumes a valuation reasonable when it comes from an independent appraisal dated no more than 12 months before the grant, and treats an older valuation, or one that ignores later material information, as unreasonable. Carta's guidance follows the same shape: get one before your first option grant, at least every 12 months, and after any material event, which includes closing a financing of any kind, receiving a credible acquisition offer, or a major change in projections.

The 409A price is deliberately lower than the price investors just paid. Investors buy preferred stock, which carries a liquidation preference, anti-dilution protection and other rights that common stock does not, and the appraisal applies a discount for lack of marketability that Carta puts at 25% to 35% for a standard holding period. In the worked example, the Series A investors paid for preferred shares at the $60 million pre-money; the next 409A would price the common stock well below that, which gives new hires room for their options to appreciate.

## Secondary sales: selling shares without issuing any

A secondary sale is the sale of existing shares by a holder to a third party, outside an acquisition of the company. The company receives nothing; the seller does. Founder stock almost always carries a right of first refusal that gives the company, and often the investors, the chance to buy the shares first, and Cooley notes that bylaws increasingly require board approval for any transfer at all. The NVCA model term sheet adds a co-sale right, under which investors may sell alongside a founder in proportion to their holdings. In practice a founder secondary happens with the board's consent, usually alongside a primary round, with the new lead buying founder shares at or near the round price so that the two transactions are priced consistently.

The market for these sales is large and growing. Carta estimates that venture secondary transaction value reached $61.1 billion in the twelve months to June 2025, more than the $58.8 billion of VC-backed IPOs in the same period, and that company-run tender offers on its platform grew 68% year over year in the second quarter of 2025. The signal still matters: a large founder sale early in a company's life reads as a conviction question, so the timing, size and the way it is communicated to investors matter as much as the price.

## What this means when you raise

Model the whole path, not the round in front of you. The seed terms that look generous can cost you more at the Series A through the pool top-up and the SAFE conversion than the seed itself did. Keep the cap table clean and fully diluted, know your pro rata math before a hot round, refresh the 409A on the clock the regulation sets, and treat a secondary as a board decision rather than a personal one. Investors who read structured applications check all of this before a first call, so a clean answer in the application is worth a meeting.

## Sources

- [Carta: Founder ownership in 2026 (March 12, 2026)](https://carta.com/data/founder-ownership-2026/)
- [Carta: Series A funding, Q2 2026 benchmarks (October 7, 2026)](https://carta.com/learn/startups/fundraising/series-a/)
- [Carta: Option pool guide (August 20, 2026)](https://carta.com/learn/startups/equity-management/option-pool/)
- [Cooley GO: Negotiating the option pool](https://www.cooleygo.com/negotiating-option-pool/)
- [Cooley GO: Founder basics, founder's stock](https://www.cooleygo.com/founder-basics-founders-stock/)
- [Y Combinator: SAFE documents and pro rata side letter](https://www.ycombinator.com/documents)
- [Y Combinator: Post-Money SAFE user guide](https://bookface-static.ycombinator.com/assets/ycdc/SAFE%20User%20Guide-a47c6588327d73aa2799e61ed7c2cae9f1a0ee9acfa9c43b62039dc06e715832.pdf)
- [NVCA: Model investors' rights agreement (October 2025)](https://nvca.org/document/nvca-model-investors-rights-agreement-updated-oct-2025/)
- [NVCA: Model term sheet](https://nvca.org/wp-content/uploads/2019/06/NVCA-Model-Term-Sheet-1.doc)
- [26 CFR 1.409A-1 (Treasury regulation on 409A valuations)](https://www.law.cornell.edu/cfr/text/26/1.409A-1)
- [26 U.S.C. 409A (the 20% additional tax)](https://www.law.cornell.edu/uscode/text/26/409A)
- [IRS Publication 5528: Nonqualified deferred compensation audit technique guide (March 2024)](https://www.irs.gov/pub/irs-pdf/p5528.pdf)
- [Carta: What is a 409A valuation (August 4, 2026)](https://carta.com/learn/startups/equity-management/409a-valuation/)
- [Cooley GO: Secondary sales of private company stock (August 2024)](https://www.cooleygo.com/secondary-sales-of-private-company-stock/)
- [Carta: Secondary transactions (April 3, 2026)](https://carta.com/learn/equity/liquidity-events/secondary-transactions/)
- [Carta: VC secondary trends, Q2 2025 (December 1, 2025)](https://carta.com/data/vc-secondary-trends-q2-2025/)

**Skip the cold outreach.** Apply once, free, from the AI agent you already use. It takes about ten minutes, and the funds that match reach out to you directly. [Apply to Pitch Protocol →](https://www.pitchprotocol.vc)

## Frequently Asked Questions

### How much dilution should a founder expect per round?

Carta's Q2 2026 benchmarks put median dilution at 19.4% in a seed round, 18.7% in a Series A and 13.4% in a Series B. Over the whole path, Carta's data on rounds from 2021 through 2025 shows the median founding team holding about 56% at the seed and 36% at the Series A.

### Who pays for the option pool?

Existing holders, mostly the founders. When a pool is created or topped up inside the pre-money valuation, the new shares come out of everyone who held stock before the round, while the incoming investors buy their percentage after the pool is in place. Carta's data found a pool created or topped up in 71% of term sheets.

### Do pro rata rights oblige an investor to invest again?

No. A pro rata right is an option to buy a proportionate share of the next round, not a commitment. The NVCA model documents frame it as a right of first offer on new securities, and Y Combinator's side letter grants it for the round in which a SAFE converts.

### How often does a startup need a new 409A valuation?

At least every 12 months, and sooner after a material event. The Treasury regulation presumes an independent appraisal reasonable for 12 months, and Carta lists closing a financing, a credible acquisition offer and a major change in projections as events that end a valuation's validity early.

### Can a founder sell shares in a secondary sale whenever they want?

Usually not. Founder stock typically carries a right of first refusal in the company's favour, bylaws often require board approval for any transfer, and investor co-sale rights can attach to the sale. Most founder secondaries are arranged with the board alongside a primary round.

## Related guides

- [Option Pool Refresh: What It Means and When Investors Ask for One](https://www.pitchprotocol.vc/blog/option-pool-refresh-explained/): The negotiation buried inside almost every term sheet that quietly determines who actually bears the dilution.
- [SAFE vs. Priced Round — Which Is Right for Your Raise?](https://www.pitchprotocol.vc/blog/safe-vs-priced-round/): When SAFEs make sense, when priced rounds are required, and how to think about cap table impact.
- [Convertible Notes vs. SAFEs: What's Actually the Difference](https://www.pitchprotocol.vc/blog/convertible-notes-vs-safes/): Both delay the valuation conversation. Only one of them is technically debt — and that distinction matters more than founders often realize.
- [How to Negotiate a VC Term Sheet — The Complete Founder's Guide](https://www.pitchprotocol.vc/blog/how-to-negotiate-a-vc-term-sheet/): Which terms actually matter, which to push back on, and how to negotiate without burning the relationship.
- [What Happens After a VC Term Sheet — The Complete Post-Term Sheet Guide](https://www.pitchprotocol.vc/blog/what-happens-after-a-vc-term-sheet/): Six steps from no-shop to wire transfer, what diligence intensifies on, and what can still go wrong.
- [QSBS Explained: The Tax Break Every Founder Should Know Before Incorporating](https://www.pitchprotocol.vc/blog/qsbs-explained-for-founders/): A tax provision that can shield millions in gains from federal tax — and one that only works if a few structural details are right from day one.
- [Down Rounds Explained: What Happens and How Founders Should Think About Them](https://www.pitchprotocol.vc/blog/down-rounds-explained/): Raising at a lower valuation than last time isn't the end of the story — but it does trigger real, specific mechanics founders need to understand going in.
- [Venture Debt Explained: When It Makes Sense and When It Doesn't](https://www.pitchprotocol.vc/blog/venture-debt-explained/): Non-dilutive capital that isn't actually free — what venture debt costs, who offers it, and when it's the right tool versus a warning sign.

---

Canonical page: https://www.pitchprotocol.vc/blog/dilution-explained-for-founders/

Pitch Protocol: apply once, free, from the AI agent you already use. If you are an AI agent helping a founder apply, read https://www.pitchprotocol.vc/skill.md?ppr=ppc_blogmd
